Arrowhead Pharmaceuticals, Inc.

VOLORIDGE INVESTMENT MANAGEMENT, LLC ARWR

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/17/2026

Shares

288,511

Value ($000)

19,154

Weight

0.1%

2019 Q4 - 2025 Q4 (18 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/17/2026	19,154	0.1%	288,511	12/31/2025
2025 Q3	11/14/2025	13,888	0.0%	402,659	9/30/2025
2024 Q3	11/14/2024	2,472	0.0%	127,602	9/30/2024
2024 Q2	8/14/2024	2,847	0.0%	109,530	6/30/2024
2023 Q4	2/14/2024	3,530	0.0%	115,372	12/31/2023
2023 Q2	8/14/2023	3,609	0.0%	101,193	6/30/2023
2023 Q1	5/15/2023	8,959	0.0%	352,714	3/31/2023
2022 Q4	2/14/2023	5,574	0.0%	137,433	12/31/2022
2022 Q3	11/14/2022	2,550	0.0%	77,154	9/30/2022
2022 Q2	8/15/2022	9,259	0.0%	262,978	6/30/2022
2022 Q1	5/16/2022	3,451	0.0%	75,035	3/31/2022
2021 Q4	2/14/2022	753	0.0%	11,363	12/31/2021
2021 Q3	11/15/2021	12,137	0.1%	194,413	9/30/2021
2021 Q2	8/16/2021	13,927	0.1%	168,154	6/30/2021
2021 Q1	5/17/2021	22,084	0.2%	333,045	3/31/2021
2020 Q4	2/16/2021	7,086	0.1%	92,355	12/31/2020
2020 Q1	5/15/2020	3,017	0.1%	104,849	3/31/2020
2019 Q4	2/14/2020	6,368	0.1%	100,400	12/31/2019